|
Apr 4
|
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
|
|
Apr 2
|
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
|
|
Mar 26
|
Masimo (MASI) Soars 3.3%: Is Further Upside Left in the Stock?
|
|
Mar 20
|
PROCEPT BioRobotics Corp (PRCT) President and CEO Reza Zadno Sells Company Shares
|
|
Mar 8
|
EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics Corp (PRCT)
|
|
Mar 7
|
Director Thomas Krummel Sells 20,000 Shares of PROCEPT BioRobotics Corp (PRCT)
|
|
Jan 12
|
EVP, CLO, CORP. SEC. Alaleh Nouri Sells 16,000 Shares of PROCEPT BioRobotics Corp
|
|
Jan 10
|
Strength Seen in PROCEPT BioRobotics Corporation (PRCT): Can Its 15.1% Jump Turn into More Strength?
|
|
Jan 8
|
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
|
|
Dec 10
|
Insider Sell Alert: Director Frederic Moll Sells 79,000 Shares of PROCEPT BioRobotics Corp (PRCT)
|
|
Dec 9
|
EVP, CFO Kevin Waters Sells 15,085 Shares of PROCEPT BioRobotics Corp (PRCT)
|
|
Dec 5
|
PROCEPT BioRobotics Stock Scores Rising Relative Strength
|
|
Nov 6
|
Wall Street Analysts Predict a 25.54% Upside in PROCEPT BioRobotics Corporation (PRCT): Here's What You Should Know
|
|
Nov 2
|
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
Q3 2023 PROCEPT BioRobotics Corp Earnings Call
|
|
Sep 20
|
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
|
|
Sep 12
|
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
|